FDA Inspection 1229376 — Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)
The FDA completed an inspection of Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) on January 16, 2024 in Lianyungang. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- January 16, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lianyungang (China)